These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33331657)

  • 61. Telomere-length dependent T-cell clonal expansion: A model linking ageing to COVID-19 T-cell lymphopenia and mortality.
    Anderson JJ; Susser E; Arbeev KG; Yashin AI; Levy D; Verhulst S; Aviv A
    EBioMedicine; 2022 Apr; 78():103978. PubMed ID: 35367774
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cushing syndrome and glucocorticoids: T-cell lymphopenia, apoptosis, and rescue by IL-21.
    Hwang S; Tatsi C; Kuehn HS; Niemela JE; Stoddard J; Su Y; Lodish M; Uzel G; Spolski R; Leonard WJ; Holland SM; Fleisher TA; Stratakis CA; Rosenzweig SD
    J Allergy Clin Immunol; 2022 Jan; 149(1):302-314. PubMed ID: 34089750
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epigenetic immune monitoring for COVID-19 disease course prognosis.
    Samans B; Rosselló Chornet M; Rosselló Chornet A; Jung J; Schildknecht K; Lozza L; Alos Zaragoza L; Hernández Laforet J; Babel N; Olek S
    Front Immunol; 2023; 14():1107900. PubMed ID: 36999021
    [TBL] [Abstract][Full Text] [Related]  

  • 64. T-cell lymphocytopenia: An omnipresent predictor of morbidity and mortality in consequence of SARS-CoV disease and influenza A infections.
    Putter JS; Seghatchian J
    Cytokine; 2023 May; 165():156163. PubMed ID: 36989654
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lymphopenia: A useful predictor of COVID-19 disease severity and mortality.
    Toori KU; Qureshi MA; Chaudhry A
    Pak J Med Sci; 2021; 37(7):1984-1988. PubMed ID: 34912430
    [TBL] [Abstract][Full Text] [Related]  

  • 66. T-cell cellular stress and reticulocyte signatures, but not loss of naïve T lymphocytes, characterize severe COVID-19 in older adults.
    Jergović M; Watanabe M; Bhat R; Coplen CP; Sonar SA; Wong R; Castaneda Y; Davidson L; Kala M; Wilson RC; Twigg HL; Knox K; Erickson HE; Weinkauf CC; Bime C; Bixby BA; Parthasarathy S; Mosier JM; LaFleur BJ; Bhattacharya D; Nikolich JZ
    Geroscience; 2023 Jun; 45(3):1713-1728. PubMed ID: 36633825
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lymphopenia in sepsis-an acquired immunodeficiency?
    Finfer S; Venkatesh B; Hotchkiss RS; Sasson SC
    Immunol Cell Biol; 2023 Jul; 101(6):535-544. PubMed ID: 36468797
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sex distinctions regarding serum zinc levels in critically ill COVID-19 patients.
    Pereira CGM; Nunes MAP; Lessa AL; Cerqueira LC; Veloso OM; Delpino FM; Ferreira A; de Góis FN; Costa PSR; Santos HO
    J Trace Elem Med Biol; 2023 Sep; 79():127262. PubMed ID: 37451092
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Duration from onset to discharge is longer in COVID-19 patients with low blood regulatory T-cell counts.
    Kaya H; Usuda D
    J Med Virol; 2022 Mar; 94(3):840-841. PubMed ID: 34661300
    [No Abstract]   [Full Text] [Related]  

  • 70. Lymphopenia in Covid-19: A single center retrospective study of 589 cases.
    Ghizlane EA; Manal M; Abderrahim EK; Abdelilah E; Mohammed M; Rajae A; Amine BM; Houssam B; Naima A; Brahim H
    Ann Med Surg (Lond); 2021 Sep; 69():102816. PubMed ID: 34512964
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact.
    Zhang S; Asquith B; Szydlo R; Tregoning JS; Pollock KM
    Immunother Adv; 2021 Jan; 1(1):ltab015. PubMed ID: 35965490
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lymphopenia and Mechanisms of T-Cell Regeneration.
    Saidakova EV
    Cell tissue biol; 2022; 16(4):302-311. PubMed ID: 35967247
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Self-Limited COVID-19 in a Patient with Artemis Hypomorphic SCID.
    Gabryszewski SJ; England RN; Sun D; Gentile TL; Hochgertel W; Jyonouchi S; Silverman M; Zaoutis T; Sullivan KE; Henrickson SE
    J Clin Immunol; 2021 Nov; 41(8):1745-1747. PubMed ID: 34420125
    [No Abstract]   [Full Text] [Related]  

  • 74. Down to a T: The Functional Importance of Lymphopenia in Severe COVID-19.
    Shahridan Faiez T; Singanayagam A
    Am J Respir Crit Care Med; 2022 Jun; 205(12):1370-1372. PubMed ID: 35452367
    [No Abstract]   [Full Text] [Related]  

  • 75. The putative mechanism of lymphopenia in COVID-19 patients.
    Wang X; Liu Z; Lu L; Jiang S
    J Mol Cell Biol; 2022 Aug; 14(5):. PubMed ID: 35641108
    [No Abstract]   [Full Text] [Related]  

  • 76. What is the cause of lymphopenia in malaria?
    Hviid L; Kemp K
    Infect Immun; 2000 Oct; 68(10):6087-9. PubMed ID: 11203040
    [No Abstract]   [Full Text] [Related]  

  • 77. COVID-19 Therapy: Could a Copper Derivative of Chlorophyll
    Clark NF; Taylor-Robinson AW
    Front Med (Lausanne); 2021; 8():620175. PubMed ID: 33777973
    [No Abstract]   [Full Text] [Related]  

  • 78. Do Low-Density Granulocytes Induce Lymphopenia in Patients with COVID-19?
    Mortaz E; Garssen J; Adcock I
    Iran J Allergy Asthma Immunol; 2022 Jun; 21(3):369-373. PubMed ID: 35822687
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Long Covid clues emerge from patients' blood.
    Couzin-Frankel J
    Science; 2022 Aug; 377(6608):803. PubMed ID: 35981036
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Correction: Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.
    Tan L; Wang Q; Zhang D; Ding J; Huang Q; Tang YQ; Wang Q; Miao H
    Signal Transduct Target Ther; 2020; 5(1):61. PubMed ID: 32377400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.